Browse 1,492 gastrointestinal clinical trials enrolling across the United States and Canada. 173 people applied to gastrointestinal studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 1,492
Active & Responsive
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
for
Breast Cancer, Endometrial Cancer, Ovarian Cancer,
Location: Boston MA, Fairfax VA, Orlando FL, Cleveland OH,
Sponsor: Terremoto Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07109726
Phase 1, Phase 2, Recruiting
Active & Responsive
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
for
Pouchitis
Location: New York NY, Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18 - 70+
Code: NCT06312683
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: London, Halifax, Providence RI, New York NY, Montreal,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase 2, Recruiting
Active & Responsive
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
for
Inflammatory Bowel Diseases
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18+
Code: NCT06188793
Recruiting
Active & Responsive
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Hartford CT, New York NY, Englewood NJ, Florham Park NJ,
Sponsor: VM Oncology, LLC
Sex: All
Age: 18 - 70+
Code: NCT03556228
Phase 1, Phase 2, Recruiting
Active & Responsive
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
for
Colorectal Carcinoma Metastatic in the Liver
Location: Providence RI
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT06555133
Phase 2, Recruiting
Active & Responsive
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
for
Colorectal Cancer
Location: York PA, Bethesda MD, Goldsboro NC, Canton OH,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05234177
Recruiting
Active & Responsive
Protein Needs Study
for
Colorectal Cancer, Breast Cancer
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 45 - 70+
Code: NCT04144907
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Boston MA, Providence RI, North Massapequa NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase 3, Recruiting
Active & Responsive
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
for
Eosinophilic Esophagitis (EoE)
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: All
Age: 22+
Code: NCT06665971
Recruiting
Active & Responsive
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)